BackSinovac Biotech, Overview

Sinovac Biotech, Intangible Assets

Latest intangible assets for SVA: $140M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$139.85M

Peer trimmed avg / median

Loading

Sinovac Biotech, Intangible Assets History

Loading

Sinovac Biotech, vs. peers: Intangible Assets Comparison

Loading

Sinovac Biotech, Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sinovac Biotech, (SVA) FAQ

The latest intangible assets for SVA is $140M as of December 2025. Investors often review this figure alongside Sinovac Biotech,'s historical trend and sector peers before judging valuation or financial health.

A intangible assets figure of $140M for SVA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SVA's intangible assets ($140M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sinovac Biotech,'s intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.